Janus Henderson Global Life Sciences Fund Class T
JAGLX
NASDAQ
| Weiss Ratings | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Janus Henderson | |||
| Manager/Tenure (Years) | Andy Acker (19), Daniel Lyons (3) | |||
| Website | http://janushenderson.com | |||
| Fund Information | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Janus Henderson Global Life Sciences Fund Class T | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 31, 1998 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.33% | |||
| Dividend | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.16% | |||
| Asset Allocation | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.91% | |||
| Stock | 96.03% | |||
| U.S. Stock | 85.42% | |||
| Non-U.S. Stock | 10.61% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 2.86% | |||
| Convertible | 0.00% | |||
| Other Net | 0.19% | |||
| Price History | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.17% | |||
| 30-Day Total Return | -6.12% | |||
| 60-Day Total Return | -0.84% | |||
| 90-Day Total Return | -0.36% | |||
| Year to Date Total Return | 8.45% | |||
| 1-Year Total Return | 33.58% | |||
| 2-Year Total Return | 20.68% | |||
| 3-Year Total Return | 51.54% | |||
| 5-Year Total Return | 46.77% | |||
| Price | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $87.24 | |||
| 1-Month Low NAV | $86.84 | |||
| 1-Month High NAV | $92.93 | |||
| 52-Week Low NAV | $68.31 | |||
| 52-Week Low NAV (Date) | Sep 25, 2025 | |||
| 52-Week High NAV | $93.51 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.70 | |||
| Standard Deviation | 15.73 | |||
| Balance Sheet | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 6.03B | |||
| Operating Ratios | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.92% | |||
| Turnover Ratio | 30.00% | |||
| Performance | JAGLX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 27.38% | |||
| Last Bear Market Total Return | -8.29% | |||